ASXL1 and chronic myelomonocytic leukemia: Damm et al. reported that the SETBP1 mutations observed in about 6% of patients with CMML are likely associated with ASXL1 mutations [6], while Thol et al. demonstrated that no association was found between ASXL1 and SETBP1 mutations in his MDS patients [12].